ArticleBMC cardiovascular disorders2025
Angiotensin receptor-neprilysin inhibitors improve the outcome of lung cancer patients with hypertension undergoing immune checkpoint inhibitors treatment.
Conghui Shang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.